Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122706022 | 12270602 | 2 | F | 201509 | 20160621 | 20160415 | 20160711 | PER | US-PFIZER INC-2016165472 | PFIZER | 71.00 | YR | F | Y | 123.00000 | KG | 20160711 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122706022 | 12270602 | 1 | PS | SUTENT | SUNITINIB MALATE | 1 | Oral | 50 MG, CYCLIC (4 WEEKS ON 2 WEEKS OFF) | Y | 21938 | 50 | MG | CAPSULE, HARD | ||||||
| 122706022 | 12270602 | 2 | SS | SUTENT | SUNITINIB MALATE | 1 | Y | 21938 | CAPSULE, HARD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122706022 | 12270602 | 1 | Renal cell carcinoma |
| 122706022 | 12270602 | 2 | Lung neoplasm malignant |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122706022 | 12270602 | Fungal infection | |
| 122706022 | 12270602 | Oral pain |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122706022 | 12270602 | 1 | 20160304 | 0 |